Clinical Trials Directory

Trials / Completed

CompletedNCT04944498

Modified Tarsorrhaphy vs Gold Weight Implant for Paralytic Lagophthalmos in Leprosy Patients

Modified Tarsorrhaphy vs Gold Weight Implant Technique for Paralytic Lagophthalmos Treatment in Leprosy Patients: a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Yunia Irawati · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the effectivity and efficiency of Modified Tarsorrhaphy (MT) technique and Gold Weight Implant (GWI) technique as a surgical treatment of paralytic lagophthalmos in leprosy patients. The hypothesis is that MT technique is more effective and more efficient than GWI technique. This study used PROBE (Prospective Randomized Open-label Blinded-Endpoint) clinical trial. Samples consisted of 14 eyes in MT group and 13 eyes in GWI group as the control group. This study was conducted in 3 hospitals in Indonesia and the patients were observed in 1 year period.

Conditions

Interventions

TypeNameDescription
PROCEDUREModified TarsorrhaphyA combination of levator recess, lateral tarsorrhaphy of 10 mm, and lateral canthopexy/lateral tarsal strip
PROCEDUREGold Weight ImplantInstallation of 1,5 gram gold weight implant above tarsal plate and underneath levator recess

Timeline

Start date
2019-05-09
Primary completion
2020-02-09
Completion
2021-04-04
First posted
2021-06-29
Last updated
2021-06-29

Locations

3 sites across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04944498. Inclusion in this directory is not an endorsement.